Efficacy of a unique omega-3 formulation on the correction of nutritional deficiency and its effects on cardiovascular disease risk factors in a randomized controlled VASCAZEN(®) REVEAL Trial.
about
Oxidation levels of North American over-the-counter n-3 (omega-3) supplements and the influence of supplement formulation and delivery form on evaluating oxidative safetyEffect of long chain omega-3 polyunsaturated fatty acids on inflammation and metabolic markers in hypertensive and/or diabetic obese adults: a randomized controlled trial
P2860
Efficacy of a unique omega-3 formulation on the correction of nutritional deficiency and its effects on cardiovascular disease risk factors in a randomized controlled VASCAZEN(®) REVEAL Trial.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Efficacy of a unique omega-3 f ...... randomized controlled VASCAZEN
@nl
Efficacy of a unique omega-3 f ...... lled VASCAZEN(®) REVEAL Trial.
@ast
Efficacy of a unique omega-3 f ...... lled VASCAZEN(®) REVEAL Trial.
@en
type
label
Efficacy of a unique omega-3 f ...... randomized controlled VASCAZEN
@nl
Efficacy of a unique omega-3 f ...... lled VASCAZEN(®) REVEAL Trial.
@ast
Efficacy of a unique omega-3 f ...... lled VASCAZEN(®) REVEAL Trial.
@en
prefLabel
Efficacy of a unique omega-3 f ...... randomized controlled VASCAZEN
@nl
Efficacy of a unique omega-3 f ...... lled VASCAZEN(®) REVEAL Trial.
@ast
Efficacy of a unique omega-3 f ...... lled VASCAZEN(®) REVEAL Trial.
@en
P2093
P2860
P1476
Efficacy of a unique omega-3 f ...... lled VASCAZEN(®) REVEAL Trial.
@en
P2093
Bruce Holub
Carla Cockerline
George Jackowski
Jason Yantha
Maggie Laidlaw
Nisar A Shaikh
Sabah Shaikh
William Rowe
P2860
P2888
P356
10.1007/S11010-014-2132-1
P577
2014-09-04T00:00:00Z
P5875
P6179
1000998312